PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 62, Issue 6, Pages 1858-1869
Publisher
Wiley
Online
2015-07-01
DOI
10.1002/hep.27965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-translational modifications of intermediate filament proteins: mechanisms and functions
- (2014) Natasha T. Snider et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- When Lamins Go Bad: Nuclear Structure and Disease
- (2013) Katherine H. Schreiber et al. CELL
- Depletion of extracellular signal-regulated kinase 1 in mice with cardiomyopathy caused by lamin A/C gene mutation partially prevents pathology before isoenzyme activation
- (2013) W. Wu et al. HUMAN MOLECULAR GENETICS
- Distinct and redundant roles of the non-muscle myosin II isoforms and functional domains
- (2012) Aibing Wang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Nonmuscle myosin-2: mix and match
- (2012) Sarah M. Heissler et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Generic and Personalized RNAi-Based Therapeutics for a Dominant-Negative Epidermal Fragility Disorder
- (2012) Deena M. Leslie Pedrioli et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Nuclear lamin functions and disease
- (2012) Veronika Butin-Israeli et al. TRENDS IN GENETICS
- Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene
- (2011) A. Muchir et al. CARDIOVASCULAR RESEARCH
- Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene
- (2010) Wei Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- FLT3 inhibition as a targeted therapy for acute myeloid leukemia
- (2010) Miguel Sanz et al. CURRENT OPINION IN ONCOLOGY
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Modulation of Keratin Expression by Sulforaphane Occurs via Nrf2-dependent and -independent Pathways in Skin Epithelia
- (2010) Michelle Kerns et al. MOLECULAR BIOLOGY OF THE CELL
- Protein kinase inhibition of clinically important staurosporine analogues
- (2010) Osman A. B. S. M. Gani et al. NATURAL PRODUCT REPORTS
- “IF-pathies”: a broad spectrum of intermediate filament–associated diseases
- (2009) M. Bishr Omary JOURNAL OF CLINICAL INVESTIGATION
- Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility
- (2009) Pierre A. Coulombe et al. JOURNAL OF CLINICAL INVESTIGATION
- Toward unraveling the complexity of simple epithelial keratins in human disease
- (2009) M. Bishr Omary et al. JOURNAL OF CLINICAL INVESTIGATION
- Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation
- (2008) G-Z Tao et al. JOURNAL OF PATHOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
- The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases
- (2007) Ildiko Szeverenyi et al. HUMAN MUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation